New Key Statistics Module, Z-Score and F-Score
NAS:ABEO Key Ratios
| Market Cap $ M | 309.94 |
| Enterprise Value $ M | 182.98 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 78.76 |
| Price/Book | 2.42 |
| Price/Sales | 12.49 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 25.00 |
| EPS (TTM) $ | -1.17 |
| Beneish M-Score | 54.3 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -229.40 |
| EV-to-EBIT | -2.44 |
| EV-to-EBITDA | -2.57 |
| PEG | -- |
| Shares Outstanding M | 57.18 |
| Net Margin (%) | -246.42 |
| Operating Margin % | -327.65 |
| Pre-tax Margin (%) | -306.81 |
| Quick Ratio | 6.40 |
| Current Ratio | 6.63 |
| ROA % (ttm) | -29.25 |
| ROE % (ttm) | -40.99 |
| ROIC % (ttm) | -220.97 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.77 |
ABEO Number of Guru Trades
ABEO Volume of Guru Trades
Gurus Latest Trades with NAS:ABEO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABEO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Abeona Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ABEO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers